Skip to main content
. 2020 Mar 2;9(1):1728871. doi: 10.1080/2162402X.2020.1728871

Figure 5.

Figure 5.

Therapeutic efficacy of RT53-treated APL blast vaccination in well-established leukemia. 104 APL blasts were inoculated i.v. into FVB/N mice at day 0. Mice were then vaccinated with RT53-treated APL blast 3 or 10 days after leukemia engraftment (n = 5 per group). Survival curves were analyzed with the Mantel–Cox test. The schematic protocol used is illustrated (right panel).